Neisseria gonorrhoeae ciprofloxacin susceptibility testing and gyrA targets
- PMID: 37236216
- DOI: 10.1016/S2666-5247(23)00149-0
Neisseria gonorrhoeae ciprofloxacin susceptibility testing and gyrA targets
Comment in
-
Neisseria gonorrhoeae ciprofloxacin susceptibility testing and gyrA targets - Authors' reply.Lancet Microbe. 2023 Aug;4(8):e575. doi: 10.1016/S2666-5247(23)00150-7. Epub 2023 May 23. Lancet Microbe. 2023. PMID: 37236213 Free PMC article. No abstract available.
Comment on
-
Neisseria gonorrhoeae diagnostic escape from a gyrA-based test for ciprofloxacin susceptibility and the effect on zoliflodacin resistance: a bacterial genetics and experimental evolution study.Lancet Microbe. 2023 Apr;4(4):e247-e254. doi: 10.1016/S2666-5247(22)00356-1. Epub 2023 Feb 28. Lancet Microbe. 2023. PMID: 36868257 Free PMC article.
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Medical